Run time: 91m

  5      0

2019 AABB Annual Meeting On-Demand

ST1-08: Developing a Training Program for Future Cellular Therapy Professionals

Oct 19, 2019 8:00am ‐ Oct 19, 2019 9:30am

Expiration Date: Dec 31, 2021

Credits: None available.

Standard: $25.00
Members: $20.00


The rapidly growing field of cellular therapy faces a major challenge in the availability of qualified professionals. From technologists to laboratory directors, the current training environment simply has not kept up with the rapid expansion and the novel nature of this exciting new field. Regular medical technologists lack the experience in a current Good Manufacturing Practice (cGMP) environment. Most transfusion medicine trainees have little exposure to the field of cellular therapy, whether it is standard of care, or investigational. There are currently no accredited cellular therapy fellowships by the Accreditation Council for Graduate Medical Education (ACGME). 

This session intend to showcase some of the existing cellular therapy programs, from short to long ones. It aims to bring to the audience's attention currently available, albeit limited, training opportunities in cellular therapy. Furthermore, it also hopes to stimulate attendee's own desire to bring such need back to their own institutions and perhaps design a training program of their own. Only with a pipeline of well trained professionals can this field truly achieve its potential.

Learning Objectives:

  • Appreciate the lack of training opportunities in cellular therapy.
  • Identify currently available training programs in cellular therapy.
  • Design their own training program, depending on the trainees targeted and scope/resources available.



  • Christina Celluzzi, PhD : <p>Nothing to Disclose</p>
  • David McKenna, MD : <p>Nothing to Disclose</p>
  • Yongping Wang : <p>Nothing to Disclose</p>

Credits Available

ST1-08: Developing a Training Program for Future Cellular Therapy Professionals Evaluation

You must be logged in and own this session in order to post comments.